BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/12/2025 1:38:08 AM | Browse: 50 | Download: 0
Category |
Transplantation |
Manuscript Type |
Retrospective Study |
Article Title |
Implementation of an opioid-sparing protocol utilizing liposomal bupivacaine and intravenous ketorolac for pain management after living kidney donation
|
Manuscript Source |
Invited Manuscript |
All Author List |
Kevin Ly, Antonio Di Carlo, Sunil S Karhadkar, Kenneth Chavin, Francesca Graziano, Kelley Maberry, Nicole Sifontis, Daohai Yu, Xiaoning Lu and Adam Diamond |
Funding Agency and Grant Number |
|
Corresponding Author |
Kevin Ly, PharmD, Department of Pharmacy, Temple University Hospital, 3401 N. Broad Street, Philadelphia, PA 19140, United States. kevin.ly@tuhs.temple.edu |
Key Words |
Opioid; Pain management; Bupivacaine; Ketorolac; Nephrectomy; Living Donation; Renal transplant |
Core Tip |
Opioids are commonly used for management of post-operative pain in living kidney donors. Reducing exposure to opioids is desirable to minimize risk of dependence and potential side effects such as nausea, vomiting, and constipation which may delay discharge. Liposomal bupivacaine, ketorolac, and scheduled acetaminophen have all demonstrated efficacy for management of post-operative pain in this population. The purpose of this retrospective chart review study is to assess the efficacy and safety of an opioid-sparing protocol utilizing a multimodal pain management approach in living kidney donors post-nephrectomy. |
Citation |
Ly K, Di Carlo A, Karhadkar SS, Chavin K, Graziano F, Maberry K, Sifontis N, Yu D, Lu X, Diamond A. Implementation of an opioid-sparing protocol utilizing liposomal bupivacaine and intravenous ketorolac for pain management after living kidney donation. World J Transplant 2025; In press |
 |
Received |
|
2024-09-17 13:35 |
 |
Peer-Review Started |
|
2024-09-17 13:35 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-02-11 09:15 |
 |
Revised |
|
2025-02-23 13:40 |
 |
Second Decision |
|
2025-03-11 02:45 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-03-12 01:38 |
 |
Articles in Press |
|
2025-03-12 01:38 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
2220-3230 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345